Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BodyLogicMD vs EmbraceRX

BodyLogicMD
Graded #263

Higher grade

vs+4.5
EmbraceRX
Graded #362

Lower grade

The verdict

BodyLogicMD takes it — 63.1/100 to 58.6/100.

BodyLogicMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BodyLogicMD is a US telehealth and clinic network (operating since 2003) best known for bioidentical hormone replacement therapy, now offering medically supervised GLP-1 weight management alongside it.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodyLogicMD +28
73
45
Dose & formulationEmbraceRX +16
40
56
Clinical oversightEven
76
76
Labs & monitoringBodyLogicMD +12
64
52
FulfillmentEmbraceRX +13
60
73
Contract termsBodyLogicMD +6
61
55
BodyLogicMD · left barEmbraceRX · right bar

The numbers

MetricBodyLogicMDEmbraceRX
WeighScore63.1/10058.6/100
GradeCC
Scorecard rank#263#362
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
BodyLogicMD

Graded #263 · C

Strengths

  • Established since 2003 with board-certified specialists and a national network of local clinics plus telehealth
  • Integrates GLP-1 weight management with bioidentical hormone therapy and lab-based, whole-person protocols
  • Transparent $79/month membership, no insurance required, cancel anytime

Where it loses points

  • GLP-1 medication cost is not published — only the $79 membership fee is shown; drug type (compounded vs brand) not stated
  • Weight loss is secondary to the hormone-therapy core; not a GLP-1-first telehealth
  • State availability and dispensing pharmacy are not disclosed on the marketing site
EmbraceRX

Graded #362 · C

Strengths

  • Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
  • Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
  • Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)

Where it loses points

  • Pricing not shown upfront — revealed only at checkout after a dose selection
  • Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
  • Compounding pharmacy partner not named ('FDA-registered pharmacies')
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard